Ποια είναι η τιμή για Pangaea Oncology, S.A. (PANG)

Η τιμή για Pangaea Oncology, S.A. (PANG) είναι $1.84

Ποια είναι η κεφαλαιοποίηση αγοράς για Pangaea Oncology, S.A. (PANG)

Η κεφαλαιοποίηση αγοράς για Pangaea Oncology, S.A. (PANG) είναι $66.03M

Pangaea Oncology, S.A. (PANG) Τιμή και Κεφαλαιοποίηση Αγοράς

Pangaea Oncology, S.A. delivers essential medical services to cancer patients across Spain and other European Union countries. Its extensive offerings encompass advanced molecular diagnostics, which include mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression profiling. The company is also active in clinical trials and provides in vitro drug profiling, employing techniques like MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing. Furthermore, Pangaea operates a specialized Dx platform for validating companion diagnostic platforms, benchmarking them against commercial alternatives, and offering bespoke research and development services to other diagnostic firms. A key focus also involves biomarker discovery, aiming to pinpoint novel targets for targeted therapies in their pre-clinical stages. Established in 2006, Pangaea Oncology, S.A. is headquartered in Barcelona, Spain.

Η τιμή για PANG	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$145,110 $66.03M	NVDA	$5.211T	+7,892,562.97%
$126,603 $66.03M	AAPL	$4.547T	+6,885,985.87%
$115,904 $66.03M	GOOG	$4.162T	+6,304,005.62%
$100,041 $66.03M	MSFT	$3.593T	+5,441,212.43%
$77,766.62 $66.03M	AMZN	$2.793T	+4,229,701.87%

Η τιμή για PANG

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$145,110 $66.03M